-20webclip.png)
SCVC is an investment firm associated with Science Creates that backs category-defining technology startups.
Portfolio
3
companies
Delta.g
Delta.g develops field-tested quantum sensors that deliver real-time spatial intelligence.
Portal Biotech
Portal Biotech delivers single-molecule protein sequencing technology to transform proteomics and drug discovery.
Zero Point Motion
Zero Point Motion develops ultra-sensitive motion sensors for GPS-denied environments.
Harry Destecroix
Founder of Science Creates, and cofounder/ managing partner of SCVC
John Williams
General Partner
Serendipity Capital led the round with participation from NSSIF and SCVC.
"We’re thrilled by the strong investor support at this early stage. This raise is more than capital; it’s a vote of confidence in our mission to make quantum sensing operational. We’re building the tools to see what others can’t, in places that matter most, from hidden sinkholes to critical infrastructure. With this funding, we’re accelerating our roadmap to deliver smaller and more nimble field-ready systems."
The financing will be used to expand technical teams and accelerate the commercialisation of its proteomics platform.
"Portal Biotech’s technology offers unprecedented capabilities in protein identification and characterisation, providing unmatched detail on protein structure and modifications at the single-molecule level on accessible desktop instruments that bring this state-of-the-art characterisation to any lab. These powerful advances are essential for accelerating drug discovery and enhancing diagnostic precision, positioning Portal Biotech as the frontrunner in the race to unlock the full potential of protein sequencing."
The Bristol startup raised the capital from SCVC, Foresight Venture Capital, and Verve Ventures to scale operations and accelerate sensor deployment.
"Our mission is to harness light to redefine the future of sensing."
-20webclip.png)
